Michal Armoni
Institute of Endocrinology
Diabetes and Metabolism
Rambam Medical Center
Technion-Israel Institute of Technology
Israel
Name/email consistency: high
- FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. Armoni, M., Harel, C., Karni, S., Chen, H., Bar-Yoseph, F., Ver, M.R., Quon, M.J., Karnieli, E. J. Biol. Chem. (2006)
- Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect. Armoni, M., Kritz, N., Harel, C., Bar-Yoseph, F., Chen, H., Quon, M.J., Karnieli, E. J. Biol. Chem. (2003)
- PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro. Armoni, M., Quon, M.J., Maor, G., Avigad, S., Shapiro, D.N., Harel, C., Esposito, D., Goshen, Y., Yaniv, I., Karnieli, E. J. Clin. Endocrinol. Metab. (2002)